| GAFFX | NWAWX | GAFFX / NWAWX | |
| Total Expense Ratio | 0.29 | 0.74 | 39% |
| Annual Report Gross Expense Ratio | 0.29 | 0.86 | 34% |
| Fund Existence | 9 years | 5 years | - |
| Gain YTD | 9.292 | -7.947 | -117% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 50000 | 2,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 339B | 252M | 134,524% |
| Annual Yield % from dividends | 0.57 | 1.30 | 44% |
| Returns for 1 year | 6.09 | -10.50 | -58% |
| Returns for 3 years | 68.22 | 23.17 | 294% |
| Returns for 5 years | 24.22 | N/A | - |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| EPSIX | 24.91 | 0.03 | +0.12% |
| NYLI Epoch Global Equity Yield Inv Class | |||
| EDICX | 11.81 | 0.01 | +0.08% |
| Eaton Vance Global Income Builder C | |||
| TQCCX | 19.74 | N/A | N/A |
| Touchstone Dividend Equity C | |||
| VICVX | 22.62 | -0.01 | -0.04% |
| USA Mutuals Vice Institutional | |||
| PRHSX | 84.49 | -0.17 | -0.20% |
| T. Rowe Price Health Sciences | |||